Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (65)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Reinert, R. R.
Right arrow Articles by Lütticken, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reinert, R. R.
Right arrow Articles by Lütticken, R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (2002) 49, 61-68
© 2002 The British Society for Antimicrobial Chemotherapy

Emergence of macrolide and penicillin resistance among invasive pneumococcal isolates in Germany

Ralf René Reinerta,*, Adnan Al-Lahhama, Maria Lemperlea, Christoph Tenholtea, Claudia Briefsa, Stefan Hauptsa, Hans Hubert Gerardsb and Rudolf Lüttickena

a Institute of Medical Microbiology, National Reference Center for Streptococci, University of Aachen, Pauwelsstrasse 30, D-52074 Aachen b GlaxoSmithKline, Munich, Germany

Continuous nationwide surveillance of antibiotic resistance in invasive pneumococcal disease was performed in Germany between 1992 and 2000, with a total of 2586 strains being isolated. The average resistance rates to erythromycin and clindamycin were 7.7% and 3.5%, respectively, throughout the study period; 3.3% of strains were found to have intermediate resistance to penicillin. Over the study period an increase in both macrolide and penicillin resistance was observed. The percentage of strains exhibiting reduced susceptibility to penicillin increased from 1.8% in 1992 to 5.8% in 2000. A dramatic increase in resistance was observed with erythromycin, where the resistance rate rose from 3.0% in 1992 to 15.3% in 2000. Of the erythromycin-resistant strains, 86 (43.4%) and 111 (56.1%) belonged to the erm(B) and mef types of resistance, respectively. An analysis of macrolide consumption data during the study period showed that erythromycin resistance was highly correlated to the consumption of newer bd and od macrolides (r = 0.89, P < 0.01).

* Corresponding author. Tel: +49-241-8089-787; Fax: +49-241-8888-483; E-mail: reinert{at}rwth-aachen.de


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Antimicrob ChemotherHome page
A. K. Wierzbowski, K. Nichol, N. Laing, T. Hisanaga, A. Nikulin, J. A. Karlowsky, D. J. Hoban, and G. G. Zhanel
Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004)
J. Antimicrob. Chemother., October 1, 2007; 60(4): 733 - 740.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
M. van der Linden, A. Al-Lahham, S. Haupts, and R. R. Reinert
Clonal Spread of mef-Positive Macrolide-Resistant Streptococcus pneumoniae Isolates Causing Invasive Disease in Adults in Germany
Antimicrob. Agents Chemother., May 1, 2007; 51(5): 1830 - 1834.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
C. V. Hawkyard and R. J. Koerner
The use of erythromycin as a gastrointestinal prokinetic agent in adult critical care: benefits versus risks
J. Antimicrob. Chemother., March 1, 2007; 59(3): 347 - 358.
[Abstract] [Full Text] [PDF]

Home page
 J Trop PediatrHome page
K. A. J. Al Khaja, T. M. Al-Ansari, A. H. H. Damanhori, and R. P. Sequeira
Rational Use of Antimicrobials in Infants in Primary Care of Bahrain
J Trop Pediatr, December 1, 2006; 52(6): 390 - 393.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
M. Bergman, S. Huikko, P. Huovinen, P. Paakkari, H. Seppala, and Finnish Study Group for Antimicrobial Resistance (
Macrolide and Azithromycin Use Are Linked to Increased Macrolide Resistance in Streptococcus pneumoniae
Antimicrob. Agents Chemother., November 1, 2006; 50(11): 3646 - 3650.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
R. R. Reinert, M. van der Linden, and A. Al-Lahham
Molecular Characterization of the First Telithromycin-Resistant Streptococcus pneumoniae Isolate in Germany
Antimicrob. Agents Chemother., August 1, 2005; 49(8): 3520 - 3522.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
R. R. Reinert, S. Reinert, M. van der Linden, M. Y. Cil, A. Al-Lahham, and P. Appelbaum
Antimicrobial Susceptibility of Streptococcus pneumoniae in Eight European Countries from 2001 to 2003
Antimicrob. Agents Chemother., July 1, 2005; 49(7): 2903 - 2913.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
R. R. Reinert and A. Al-Lahham
Time-Kill Study of the Activity of Telithromycin against Macrolide-Resistant Streptococcus pneumoniae Isolates with 23S rRNA Mutations and Changes in Ribosomal Proteins L4 and L22
Antimicrob. Agents Chemother., July 1, 2005; 49(7): 3011 - 3013.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
P. Littauer, M. Sangvik, D. A. Caugant, E. A. Hoiby, G. S. Simonsen, A. Sundsfjord, and the Norwegian Macrolide Study Group
Molecular Epidemiology of Macrolide-Resistant Isolates of Streptococcus pneumoniae Collected from Blood and Respiratory Specimens in Norway
J. Clin. Microbiol., May 1, 2005; 43(5): 2125 - 2132.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
R. R. Reinert, A. Ringelstein, M. van der Linden, M. Y. Cil, A. Al-Lahham, and F.-J. Schmitz
Molecular Epidemiology of Macrolide-Resistant Streptococcus pneumoniae Isolates in Europe
J. Clin. Microbiol., March 1, 2005; 43(3): 1294 - 1300.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
S. A Voils, M. E Evans, M. T Lane, R. H Schosser, and R. P Rapp
Use of Macrolides and Tetracyclines for Chronic Inflammatory Diseases
Ann. Pharmacother., January 1, 2005; 39(1): 86 - 94.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
M. Kresken, B. Henrichfreise, S. Bagel, J. Brauers, and B. Wiedemann
High Prevalence of the ermB Gene among Erythromycin-Resistant Streptococcus pneumoniae Isolates in Germany during the Winter of 2000-2001 and In Vitro Activity of Telithromycin
Antimicrob. Agents Chemother., August 1, 2004; 48(8): 3193 - 3195.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
A. Villedieu, M. L. Diaz-Torres, A. P. Roberts, N. Hunt, R. McNab, D. A. Spratt, M. Wilson, and P. Mullany
Genetic Basis of Erythromycin Resistance in Oral Bacteria
Antimicrob. Agents Chemother., June 1, 2004; 48(6): 2298 - 2301.
[Abstract] [Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
D. E. Low, M. E. Pichichero, and U. B. Schaad
Optimizing Antibacterial Therapy for Community-Acquired Respiratory Tract Infections in Children in an Era of Bacterial Resistance
Clinical Pediatrics, March 1, 2004; 43(2): 135 - 151.
[Abstract] [PDF]

Home page
 J Antimicrob ChemotherHome page
J.-H. Song, H.-H. Chang, J. Y. Suh, K. S. Ko, S.-I. Jung, W. S. Oh, K. R. Peck, N. Y. Lee, Y. Yang, A. Chongthaleong, et al.
Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian countries: a study of the Asian Network for Surveillance of Resistant Pathogens (ANSORP)
J. Antimicrob. Chemother., March 1, 2004; 53(3): 457 - 463.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
A. B. Brueggemann and B. G. Spratt
Geographic Distribution and Clonal Diversity of Streptococcus pneumoniae Serotype 1 Isolates
J. Clin. Microbiol., November 1, 2003; 41(11): 4966 - 4970.
[Abstract] [Full Text] [PDF]

Home page
 J Med MicrobiolHome page
R. R. Reinert, S. Muckel, A. Al-Lahham, B. G. Spratt, A. B. Brueggemann, R. Hakenbeck, and R. Lutticken
Characterization of German penicillin non-susceptible serotype 23F pneumococci using multilocus sequence typing
J. Med. Microbiol., November 1, 2003; 52(11): 981 - 987.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
R. R. Reinert, A. Wild, P. Appelbaum, R. Lutticken, M. Y. Cil, and A. Al-Lahham
Ribosomal Mutations Conferring Resistance to Macrolides in Streptococcus pneumoniae Clinical Strains Isolated in Germany
Antimicrob. Agents Chemother., July 1, 2003; 47(7): 2319 - 2322.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
M. Pihlajamaki, J. Jalava, P. Huovinen, and P. Kotilainen
Antimicrobial Resistance of Invasive Pneumococci in Finland in 1999-2000
Antimicrob. Agents Chemother., June 1, 2003; 47(6): 1832 - 1835.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
R. R. Reinert, R. Lutticken, A. Bryskier, and A. Al-Lahham
Macrolide-Resistant Streptococcus pneumoniae and Streptococcus pyogenes in the Pediatric Population in Germany during 2000-2001
Antimicrob. Agents Chemother., February 1, 2003; 47(2): 489 - 493.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
M. P. Montanari, M. Mingoia, I. Cochetti, and P. E. Varaldo
Phenotypes and Genotypes of Erythromycin-Resistant Pneumococci in Italy
J. Clin. Microbiol., January 1, 2003; 41(1): 428 - 431.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
R. Sauermann, R. Gattringer, W. Graninger, A. Buxbaum, and A. Georgopoulos
Phenotypes of macrolide resistance of group A streptococci isolated from outpatients in Bavaria and susceptibility to 16 antibiotics
J. Antimicrob. Chemother., January 1, 2003; 51(1): 53 - 57.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
J. L. Paradise
A 15-Month-Old Child With Recurrent Otitis Media
JAMA, November 27, 2002; 288(20): 2589 - 2598.
[Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
D. Bogaert, N. T. Ha, M. Sluijter, N. Lemmens, R. de Groot, and P. W. M. Hermans
Molecular Epidemiology of Pneumococcal Carriage among Children with Upper Respiratory Tract Infections in Hanoi, Vietnam
J. Clin. Microbiol., November 1, 2002; 40(11): 3903 - 3908.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
C. Garcia-Rey, L. Aguilar, F. Baquero, J. Casal, and J. E. Martin
Pharmacoepidemiological Analysis of Provincial Differences between Consumption of Macrolides and Rates of Erythromycin Resistance among Streptococcus pyogenes Isolates in Spain
J. Clin. Microbiol., August 1, 2002; 40(8): 2959 - 2963.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
R. R. Reinert, A. Al-Lahham, R. Lutticken, M. Boos, and F.-J. Schmitz
Characterization of clinical Streptococcus pneumoniae strains from Germany with decreased susceptibility to fluoroquinolones
J. Antimicrob. Chemother., June 1, 2002; 49(6): 1015 - 1018.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.